A banana protective device for storing and transporting a banana carefully.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7413738 | Releasable polymeric conjugates based on biodegradable linkers Activated polymeric bicine derivatives such as, as well as conjugates made therewith are disclosed. Methods of making and using the bicine derivatives are also disclosed. ... | 08/19/2008 |
| 7202280 | Methods for the treatment and prevention of pancreatitis and for induction of liver regeneration Novel methods for treating and preventing acute and/or chronic pancreatitis are described. Additionally, novel methods for inducing liver regeneration are described. The methods may comprise administering to a patient an effective amount of a metabolically stable an... | 04/10/2007 |
| 7078047 | Cosmetic or pharmaceutical compositions comprising homopolymers and salts thereof Use of at least one material chosen from homopolymers and salts thereof of formula (I), defined herein, for moisturizing the skin, mucous membranes and/or keratin fibres, and/or as a moisturizer and/or emollient, for the skin, mucous membranes and/or keratin fibres.... | 07/18/2006 |
| 6974568 | Treatment for cough The invention discloses the existence of cannabinoid receptors in the airways, which are functionally linked to inhibition of cough. Locally acting cannabinoid agents can be administered to the airways of a subject to ameliorate cough, without causing the psychoacti... | 12/13/2005 |
| 6924391 | Alpha-amino,-thio,-oxo substituted ketones as phospholipase inhibitors Inhibitors of the cytosolic phospholypase A2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases. The inhibitors of the present invention have the general formula wherein X, Z, ... | 08/02/2005 |
| 6830754 | Amphipatic lipid dispersion Described in the present invention are a dispersion which comprises, as a dispersoid, (a) 5 to 40 wt. % of an amphipatic lipid containing, in the molecule thereof, at least one hydroxy and amide group, and (b) 2 to 55 wt. % of a surfactant in an aqueous medium; a wa... | 12/14/2004 |
| 6716882 | Highly packed polycationic ammonium, sulfonium and phosphonium lipids The present invention discloses highly packed polycationic ammonium, sulfonium and phosphonium lipid compounds useful for making lipid aggregates for delivery of macromolecules and other compounds into cells. They are especially useful for the DNA-dependent transfor... | 04/06/2004 |
| 6548552 | Absorbent article, particularly a tampon having additives that reduce toxic shock syndrome toxin production An absorbent article, particularly a tampon having additives that reduce toxic shock syndrome toxin (TST-1) production is disclosed. The tampon has a combination of an effective amount of at least one oxygen inhibiting agent and an effective amount of at ... | 04/15/2003 |
| 6395189 | Method for the control of biofilms A process is provided for both removing and controlling biofilms present in industrial cooling and process waters. The process provides a composition which includes the reaction products of an amino base, a formaldehyde, an alkylenepolyamine, and the ammo... | 05/28/2002 |
| 6350767 | Compounds with growth hormone releasing properties The present invention relates to compounds, compositions containing them, and their use for treating medical disorders resulting from a deficiency in growth hormone.... | 02/26/2002 |
| 6217914 | Ascorbic acid composition and method for treatment of aging or damaged skin An ascorbic acid-based composition and related method for the treatment of aging or photo-damaged skin is disclosed. The composition includes water and ascorbic acid, at least a portion of which has generally been pretreated by being dissolved under relat... | 04/17/2001 |
| 6218435 | Reduction of hair growth A method of reducing hair growth in a mammal includes applying, to an area of skin from which reduced hair growth is desired, a dermatologically acceptable composition containing a suppressor of the metabolic pathway for the conversion of glucose to acety... | 04/17/2001 |
| 6149822 | Bio-film control A process is provided for both removing and controlling biofilms present in industrial cooling and process waters. The process provides a composition which includes the reaction products of an amino base, a formaldehyde, an alkylenepolyamine, and the ammo... | 11/21/2000 |
| 6028114 | Use of aminothiolester derivatives in pharmaceutics Use of at least one aminothiol ester derivative for the preparation of a pharmaceutical composition intended to increase the inhibition of a character resistant to the induction of apoptosis of transformed cells, this character being due to the bc12 gene ... | 02/22/2000 |
| 6013658 | Compounds with growth hormone releasing properties There are disclosed novel synthetic peptides of formula (I) ##STR1## where A, B, D, E, F, G, J, m, n, and p are defined in the specification. Compounds of formula (I) promote the release of growth hormone in humans and animals. Growth promoting compo... | 01/11/2000 |
| 5945091 | Photo-stable cosmetic and pharmaceutical formulations containing UV-filters A method of using compounds of formula I ##STR1## in which the C.dbd.C double bond is present in E and/or Z configuration and the variables have the following meanings: R1 denotes COOR5, COR5, CONR5 R6 | 08/31/1999 |
| 5939458 | Reduction of hair growth Mammalian hair growth is reduced by applying an inhibitor of aminoacyl-tRNA synthetase to the skin.... | 08/17/1999 |
| 5908867 | Reduction of hair growth A method of reducing hair growth in a mammal includes applying, to an area of skin from which reduced hair growth is desired, a dermatologically acceptable composition containing a compound that inhibits the formation of glycoproteins, proteglycans, or gl... | 06/01/1999 |
| 5652273 | Reduction of hair growth A method of reducing hair growth in a mammal includes applying, to an area of skin from which reduced hair growth is desired, a dermatologically acceptable composition containing a suppressor of the metabolic pathway for the conversion of glucose to acety... | 07/29/1997 |
| 5651997 | Antacid compositions An antacid composition comprises, as antacid ingredients, a hydrotalcite and dihydroxyaluminium aminoacetate in such a ratio that the former/the latter equals 30/70 to 90/10 (by weight). The composition may further comprises a readily acting or rapid effe... | 07/29/1997 |
| 5648087 | Anaesthetic pharmaceutical composition comprising a general anaesthetic and selegiline The present invention relates to an anaesthetic veterinary pharmaceutical composition, comprising a general anaesthetic selected from phencyclidine derivatives such as ketamine or tiletamine, as well as 0.015 to 1.25 molar equivalents of selegiline, combi... | 07/15/1997 |
| 5587367 | Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol A pharmaceutical or cosmetic composition is disclosed comprising in combination a retinoid and a sterol capable of inhibiting the biosynthesis of cholesterol resulting in a synergistic effect in the treatment of disorders of epidermic keratinization, prol... | 12/24/1996 |
| 5374658 | Use of oxidized polyamines, especially NN'-bis-(3-propionaldehyde)-1-4-diaminobutane (spermine dialdehye) in graft treatment Described herein is the use of a substantially pure form of an oxidized polyamine, and especially spermine dialdehyde, in the treatment of tissue grafts or other organs for transplantation. The compounds and treatment are especially useful in treating gra... | 12/20/1994 |
| 5281622 | Method of treating inflammation and pain with 2-(N-substituted-aminoalkyl)-5-(E)-alkylidene cyclopentanones, 2-(N-substituted-aminoalkyl)-5-(E)-arylalkylidene cyclopentanones, and derivatives thereof Novel 2-(N-substituted-aminoalkyl)-5-(E)-alkylidene cyclopentanones, 2-(N-substituted-aminoalkyl)-5-(E)-arylalkylidene cyclopentanones, and derivatives thereof having the formula ##STR1## wherein x is methylene or ethylene; R1 is dimethyla... | 01/25/1994 |
| 5177083 | Drugs effective against retroviruses A method to treat or prevent retroviral infection by administering a novel conjugate is described. Lucifer Yellow and its analogs are conjugated to compounds having carbonyl functional groups for reaction with the semicarbazide moiety of Lucifer Yellow to... | 01/05/1993 |
| 5171754 | Use of oxidized polyamines, especially NN'-bis-(3-propionaldehyde)-1-4-diaminobutane (spermine dialdehyde) as immunosuppressive agents This invention relates to the use of oxidized polyamines, and especially aminoaldehydes such as spermine bisaldehyde both in vitro and in vivo to elicit an immunosuppressive response in living cells. It also relates to the therapeutic application of these... | 12/15/1992 |
| 4912138 | Pharmaceutical preparation containing thiamphenicol for veterinary use Pharmaceutical preparations for veterinary use, in the form of concentrate solutions, containing Thiamphenicol as active ingredient are described. Such pharmaceutical preparations with antibiotic activity have the following compositions: _______... | 03/27/1990 |
| 4895842 | Phenylalanine derivative and proteinase inhibitor A phenylalanine derivative having the formula (I): ##STR1## where R1 and R2 are independently hydrogen provided that both R1 and R2 are not hydrogen at the same time; C1 -C8 alkyl which may... | 01/23/1990 |
| 4555400 | Synergistic preservative compositions The present provides a preservative comprising: (a) a first component selected from the group consisting of benzoic acid, formaldehyde, a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one in a ratio of about 5:1 to 1:5, b... | 11/26/1985 |
| 4446151 | Decarboxylase-inhibiting fluorinated pentane diamine derivatives Novel fluorinated diamine derivatives are inhibitors of ornithine decarboxylase enzyme and have the following general Formula I: ##STR1## wherein: Rc represents hydrogen or carboxy; R1 represents hydrogen or C1 -C6 | 05/01/1984 |